Metformin Acts on Two Different Molecular Pathways to Enhance Adult Neural Precursor Proliferation/Self-Renewal and Differentiation

Michael Fatt, Karolynn Hsu, Ling He, Fredric Wondisford, Freda D. Miller, David R. Kaplan, Jing Wang

Research output: Contribution to journalArticle

Abstract

The recruitment of endogenous adult neural stem cells for brain repair is a promising regenerative therapeutic strategy. This strategy involves stimulation of multiple stages of adult neural stem cell development, including proliferation, self-renewal, and differentiation. Currently, there is a lack of a single therapeutic approach that can act on these multiple stages of adult neural stem cell development to enhance neural regeneration. Here we show that metformin, an FDA-approved diabetes drug, promotes proliferation, self-renewal, and differentiation of adult neural precursors (NPCs). Specifically, we show that metformin enhances adult NPC proliferation and self-renewal dependent upon the p53 family member and transcription factor TAp73, while it promotes neuronal differentiation of these cells by activating the AMPK-aPKC-CBP pathway. Thus, metformin represents an optimal candidate neuro-regenerative agent that is capable of not only expanding the adult NPC population but also subsequently driving them toward neuronal differentiation by activating two distinct molecular pathways.

Original languageEnglish (US)
Pages (from-to)988-995
Number of pages8
JournalStem Cell Reports
Volume5
Issue number6
DOIs
StatePublished - Dec 8 2015

Fingerprint

Adult Stem Cells
Neural Stem Cells
Metformin
Stem cells
AMP-Activated Protein Kinases
Medical problems
Regeneration
Cell Differentiation
Brain
Repair
Transcription Factors
Cells
Therapeutics
Pharmaceutical Preparations
Population

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Developmental Biology
  • Genetics

Cite this

Metformin Acts on Two Different Molecular Pathways to Enhance Adult Neural Precursor Proliferation/Self-Renewal and Differentiation. / Fatt, Michael; Hsu, Karolynn; He, Ling; Wondisford, Fredric; Miller, Freda D.; Kaplan, David R.; Wang, Jing.

In: Stem Cell Reports, Vol. 5, No. 6, 08.12.2015, p. 988-995.

Research output: Contribution to journalArticle

Fatt, Michael ; Hsu, Karolynn ; He, Ling ; Wondisford, Fredric ; Miller, Freda D. ; Kaplan, David R. ; Wang, Jing. / Metformin Acts on Two Different Molecular Pathways to Enhance Adult Neural Precursor Proliferation/Self-Renewal and Differentiation. In: Stem Cell Reports. 2015 ; Vol. 5, No. 6. pp. 988-995.
@article{3af80bf5d0e04485acce768cc08c3421,
title = "Metformin Acts on Two Different Molecular Pathways to Enhance Adult Neural Precursor Proliferation/Self-Renewal and Differentiation",
abstract = "The recruitment of endogenous adult neural stem cells for brain repair is a promising regenerative therapeutic strategy. This strategy involves stimulation of multiple stages of adult neural stem cell development, including proliferation, self-renewal, and differentiation. Currently, there is a lack of a single therapeutic approach that can act on these multiple stages of adult neural stem cell development to enhance neural regeneration. Here we show that metformin, an FDA-approved diabetes drug, promotes proliferation, self-renewal, and differentiation of adult neural precursors (NPCs). Specifically, we show that metformin enhances adult NPC proliferation and self-renewal dependent upon the p53 family member and transcription factor TAp73, while it promotes neuronal differentiation of these cells by activating the AMPK-aPKC-CBP pathway. Thus, metformin represents an optimal candidate neuro-regenerative agent that is capable of not only expanding the adult NPC population but also subsequently driving them toward neuronal differentiation by activating two distinct molecular pathways.",
author = "Michael Fatt and Karolynn Hsu and Ling He and Fredric Wondisford and Miller, {Freda D.} and Kaplan, {David R.} and Jing Wang",
year = "2015",
month = "12",
day = "8",
doi = "10.1016/j.stemcr.2015.10.014",
language = "English (US)",
volume = "5",
pages = "988--995",
journal = "Stem Cell Reports",
issn = "2213-6711",
publisher = "Cell Press",
number = "6",

}

TY - JOUR

T1 - Metformin Acts on Two Different Molecular Pathways to Enhance Adult Neural Precursor Proliferation/Self-Renewal and Differentiation

AU - Fatt, Michael

AU - Hsu, Karolynn

AU - He, Ling

AU - Wondisford, Fredric

AU - Miller, Freda D.

AU - Kaplan, David R.

AU - Wang, Jing

PY - 2015/12/8

Y1 - 2015/12/8

N2 - The recruitment of endogenous adult neural stem cells for brain repair is a promising regenerative therapeutic strategy. This strategy involves stimulation of multiple stages of adult neural stem cell development, including proliferation, self-renewal, and differentiation. Currently, there is a lack of a single therapeutic approach that can act on these multiple stages of adult neural stem cell development to enhance neural regeneration. Here we show that metformin, an FDA-approved diabetes drug, promotes proliferation, self-renewal, and differentiation of adult neural precursors (NPCs). Specifically, we show that metformin enhances adult NPC proliferation and self-renewal dependent upon the p53 family member and transcription factor TAp73, while it promotes neuronal differentiation of these cells by activating the AMPK-aPKC-CBP pathway. Thus, metformin represents an optimal candidate neuro-regenerative agent that is capable of not only expanding the adult NPC population but also subsequently driving them toward neuronal differentiation by activating two distinct molecular pathways.

AB - The recruitment of endogenous adult neural stem cells for brain repair is a promising regenerative therapeutic strategy. This strategy involves stimulation of multiple stages of adult neural stem cell development, including proliferation, self-renewal, and differentiation. Currently, there is a lack of a single therapeutic approach that can act on these multiple stages of adult neural stem cell development to enhance neural regeneration. Here we show that metformin, an FDA-approved diabetes drug, promotes proliferation, self-renewal, and differentiation of adult neural precursors (NPCs). Specifically, we show that metformin enhances adult NPC proliferation and self-renewal dependent upon the p53 family member and transcription factor TAp73, while it promotes neuronal differentiation of these cells by activating the AMPK-aPKC-CBP pathway. Thus, metformin represents an optimal candidate neuro-regenerative agent that is capable of not only expanding the adult NPC population but also subsequently driving them toward neuronal differentiation by activating two distinct molecular pathways.

UR - http://www.scopus.com/inward/record.url?scp=84949529704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949529704&partnerID=8YFLogxK

U2 - 10.1016/j.stemcr.2015.10.014

DO - 10.1016/j.stemcr.2015.10.014

M3 - Article

C2 - 26677765

AN - SCOPUS:84949529704

VL - 5

SP - 988

EP - 995

JO - Stem Cell Reports

JF - Stem Cell Reports

SN - 2213-6711

IS - 6

ER -